Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Fama

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Hematological Oncology|May 17, 2017
Comparison of JAK2<sup>V617F</sup> -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histologyRoberto Latagliata, Nicola Polverelli, Alessia Tieghi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Leukemia & Lymphoma|August 12, 2014
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)Alessandra Tucci, Maurizio Martelli, Luigi Rigacci, et al.
Hemasphere|September 13, 2021
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic CriteriaRebecca L King, Arushi Khurana, Raphael Mwangi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 26, 2015
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, et al.
Frontiers in Oncology|August 29, 2025
Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodologyAttilio Guarini, Valentina Bozzoli, Sabino Ciavarella, et al.
British Journal of Haematology|May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American studyAngelo Fama, Jinhua Xiang, Brian K Link, et al.
Scientific Reports|December 11, 2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematologyGian Maria Zaccaria, Vito Colella, Simona Colucci, et al.
The Oncologist|April 4, 2019
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical PracticeAlessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Hematological Oncology|May 17, 2017
Comparison of JAK2<sup>V617F</sup> -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histologyRoberto Latagliata, Nicola Polverelli, Alessia Tieghi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Leukemia & Lymphoma|August 12, 2014
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)Alessandra Tucci, Maurizio Martelli, Luigi Rigacci, et al.
Hemasphere|September 13, 2021
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic CriteriaRebecca L King, Arushi Khurana, Raphael Mwangi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 26, 2015
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, et al.
Frontiers in Oncology|August 29, 2025
Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodologyAttilio Guarini, Valentina Bozzoli, Sabino Ciavarella, et al.
British Journal of Haematology|May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American studyAngelo Fama, Jinhua Xiang, Brian K Link, et al.
Scientific Reports|December 11, 2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematologyGian Maria Zaccaria, Vito Colella, Simona Colucci, et al.
The Oncologist|April 4, 2019
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical PracticeAlessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Pageof 3